Adenovirus-mediated interleukin-2 gene therapy of nociception

Gene Therapy

Volumn 10, Issue 16, 2003, Pages 1392-1399

  Yao, M Z ^a   Gu, J F ^a   Wang, J H ^a   Sun, L Y ^a   Liu, H ^a   Liu, X Y ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Adenovirus; Antinociceptive effect; Gene therapy; Interleukin 2; Intrathecal delivery; Nociception

Indexed keywords

ADENOVIRUS VECTOR; INTERLEUKIN 2; MESSENGER RNA;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CERVICAL SPINE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; GRAY MATTER; HUMAN; HUMAN CELL; HYPOTHESIS; IN SITU HYBRIDIZATION; LATENT PERIOD; LUMBAR SPINE; MALE; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PARENCHYMA; PIA MATER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SACRAL SPINAL CORD; THORACIC SPINE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WHITE MATTER;

ADENOVIRIDAE; ANIMALS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY, ACTIVE; IN SITU HYBRIDIZATION; INJECTIONS, SPINAL; INTERLEUKIN-2; NOCICEPTORS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5;

EID: 0043026994     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301992     Document Type: Article

References (33)

1. Hanisch UK, Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev 1995; 21: 246-284.
2. Jiang CL, Lu CL. Interleukin-2 and its effects in the central nervous system. Biol Signals Recept 1998; 7: 148-156.
3. Lapchak PA, Araujo DM, Quirion R, Beaudet A. Immuno-autoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience 1991; 44: 173 184.
4. Song P, Zhao ZQ, Liu XY. Expression of IL-2 receptor in dorsal root ganglion neurons and peripheral antinociception. Neuroreport 2000; 11: 1433-1436.
5. Bindoni M et al. Interleukin 2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus. Brain Res 1988; 462: 10-14.
6. Tancredi V et al. Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res 1990; 525: 149-151.
7. Jiang CL et al. The central analgesic effect of IL-2. Chin J Appl Physiol 1994; 10: 322-324.
8. Wang Y et al. Human interleukin-2 could bind to opioid receptor and induce corresponding signal transduction. Neuroreport 1996; 8: 11-14.
9. Zhao ZQ, Yang HQ, Liu XY. Inhibitory action of immunoregulator interleukin-2 on pain-sensitive spinal neurons in the cat. Chin J Neurosci 1994; 1: 37-42.
10. Song P. Zhao ZQ. Interleukin 2-induced antinociception partially coupled with mu receptor. Cytokine 2000; 12: 1240-1242.
11. Wang Y et al. The analgesic domain of IL-2. Biochem Biophys Res Commun 1997; 230: 542-545.
12. Jiang CL et al. Interleukin-2: structural and biological relatedness to opioid peptides. Neuroimmunomodulation 2000; 8: 20-24.
13. Wu X et al. Effects of intra-hippocampal injection of interleukin-2 on pain threshold and formaldehyde-induced substance P-like immunoreactivity in periaqueductal gray and spinal cord. Acta Pharmacol Sin 1999; 20: 839-843.
14. Guo H, Zhao ZQ. Inhibition of nociceptive withdrawal reflex by microinjection of interleukin 2 into rat locus coeruleus. Neuropeptides 2000; 34: 216-220.
15. Jiang CL et al. Leu-enkephalin induced by IL-2 administration mediates analgesic effect of IL-2. Neuroreport 2000; 11: 1483-1485.
16. Lotze MT et al. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. J Immunol 1985; 134: 157-166.
17. Donohue JH et al. In vivo administration of purified Jurkat-derived interleukin-2 in mice. Cancer Res 1984; 44: 1380-1386.
18. Konrad MW et al. Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Res 1990; 50: 2009-2017.
19. Yao MZ et al. Interleukin-2 gene therapy of chronic neuropathic pain. Neuroscience 2002; 112: 409-416.
20. Yao MZ et al. Interleukin-2 gene has superior antinociceptive effects when delivered intrathecally. Neuroreport 2002; 13: 791-794.
21. Finegold AA, Mannes AJ, Iadarola MJ. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther 1999; 10: 1251-1257.
22. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107.
23. Hargreaves K et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77-88.
24. Mannes AJ, Caudle RM, O'Connell BC, Iadarola MJ. Adenoviral gene transfer to spinal cord neurons: intrathecal vs intraparenchymal administration. Brain Res 1998; 793: 1-6.
25. Sharma SK, Nirnberg M, Klee WA. Morphine receptors as regulators of adenylate cyclase activity Proc Natl Acad Sci USA 1975; 72: 590-594.
26. Plata-Salaman CR, Ffrench-Mullen JM. Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons. Neuroreport 1993; 4: 579-581.
27. De Blasi S, Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA 1988; 85: 7820-7824.
28. Ding YQ, Nomura S, Kaneko T, Mizuno N. Co-localization of μ opioid receptor-like and substance P-like immunoreactivities in axon terminals within the superficial layers of the medullary and spinal dorsal horns of the rat. Neurosci Lett 1995; 198: 45-48.
29. Merighi A, Polak JM, Theodosis DT. Ultrastructural visualization of glutamate and aspartate immunoreactivities in the rat dorsal horn, with special reference to the co-localization of glutamate, substance P and calcitonin-gene related peptide. Neuroscience 1991; 40: 67-80.
30. Sun JT et al. A study of the construction of different expression vectors containing IL-2 gene and their expressions in eukaryotic cells. Acta Biochem Biophys Sin 1995; 27: 247-252.
31. Sladowski D, Steer SJ, Clothier RH, Balls M. An improved MTT assay. J Immunol Methods 1993; 157: 203-207.
32. Storkson RV, Kjorsvik A, Tjolsen A, Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 1996; 65: 167-172.
33. Milligan ED et al. A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats. J Neurosci Methods 1999; 90: 81-86.